ROCO
6539
Market cap28mUSD
Oct 08, Last price
37.40TWD
1D
-2.22%
1Q
-12.00%
Jan 2017
-95.33%
IPO
-94.54%
Name
Dv Biomed Co Ltd
Chart & performance
P/E
117.70
P/S
1.15
EPS
0.32
Div yield, %
4.08%
Shrs. gr., 5y
2.80%
Rev. gr., 5y
-15.21%
Revenues
794m
+38.46%
Net income
8m
-91.31%
CFO
58m
-51.45%
Dividend
Aug 27, 20261 TWD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
DV Biomed Co., Ltd. is engaged in the creation, production, and international sale of high-quality, medical-grade dermatological products. The company also extends its services to include wellness and weight management programs, and operates as a distributor for professional aesthetic fillers and advanced medical beauty devices. Complementing these offerings, DV Biomed supplies health-focused food items, such as functional light and energy drinks, alongside a range of facial care and broader beauty solutions. The company was established in 2011 and operates from its headquarters in Taipei, Taiwan.
Key people
Liqi Zhang
Chairman of the Board · since 2024
Mingfeng He
Chief Financial Officer, Head of Finance & Accounting · since 2021
Meixiu Chen
General Manager · since 2025
Qingjun Huang
Deputy General Manager-Administration Division · since 2018
Yujun Zhou
Head of Finance, Head of Accounting · since 2025
Mingtong Chen
Director · since 2015
Director · since 2024
Qunzhi Chen
Independent Director · since 2019
Peter Hou
Independent Director · since 2020
Independent Director · since 2018
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||